ConductScience.org, home

Paper40451925

Oncogenic function of growth arrest-specific transcript 5 by competing with miR-423-3p to regulate SMARCA4 in hepatocellular carcinoma.

Kim SY and 6 others. Exp Mol Med, 2025. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Oncogenic function of growth arrest-specific transcript 5 by competing with miR-423-3p to regulate SMARCA4 in hepatocellular carcinoma. Papers, record 40451925. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40451925

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Oncogenic function of growth arrest-specific transcript 5 by competing with miR-423-3p to regulate SMARCA4 in hepatocellular carcinoma.
PubMed
Journal
Exp Mol Med
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
1.28, provisional
iCite
Revised in PubMed
2025-07-08
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kim SYSang Yean
2Ha JWJin Woong
3Na MJMin Jeong
4Jeon SSoyoung
5Yoon JHJung Hwanhttps://orcid.org/0000-0001-7770-2965
6Park WSWon Sanghttps://orcid.org/0000-0002-9090-0584
7Nam SWSuk Woo

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, HepatocellularMajor topic
Liver NeoplasmsMajor topic
MicroRNAsMajor topic
DNA HelicasesMajor topic
Transcription FactorsMajor topic
Nuclear ProteinsMajor topic
RNA, Long NoncodingMajor topic
Gene Expression Regulation, NeoplasticMajor topic
Humans
Animals
Mice
Cell Line, Tumor
Cell Proliferation
Methyltransferases
RNA-Binding Proteins
Adenosine
Carcinogenesis

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
NRF-2022R1A2C1091808National Research Foundation of Korea (NRF)PubMed

Source PubMed

Download CSV of grants

References36

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132303701The SWI/SNF complex in cancer - biology, biomarkers and therapy.Nat Rev Clin Oncol2020https://conductscience.org/library/papers/32303701PubMed
232162380The roles of mutated SWI/SNF complexes in the initiation and development of hepatocellular carcinoma and its regulatory effect on the immune system: A review.Cell Prolif2020https://conductscience.org/library/papers/32162380PubMed
337369853Regulation and functions of non-m6A mRNA modifications.Nat Rev Mol Cell Biol2023https://conductscience.org/library/papers/37369853PubMed
429106616MODOMICS: a database of RNA modification pathways. 2017 update.Nucleic Acids Res2018https://conductscience.org/library/papers/29106616PubMed
516087271Gender-dependent hepatic alterations in H-ras12V transgenic mice.J Hepatol2005https://conductscience.org/library/papers/16087271PubMed
629171881RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.Hepatology2018https://conductscience.org/library/papers/29171881PubMed
736854773The roles of N6-methyladenosine and its target regulatory noncoding RNAs in tumors: classification, mechanisms, and potential therapeutic implications.Exp Mol Med2023https://conductscience.org/library/papers/36854773PubMed
830991448HDAC6 Suppresses Let-7i-5p to Elicit TSP1/CD47-Mediated Anti-Tumorigenesis and Phagocytosis of Hepatocellular Carcinoma.Hepatology2019https://conductscience.org/library/papers/30991448PubMed
929386218Long Noncoding RNA LINC01234 Functions as a Competing Endogenous RNA to Regulate CBFB Expression by Sponging miR-204-5p in Gastric Cancer.Clin Cancer Res2018https://conductscience.org/library/papers/29386218PubMed
1026163879Association between indel polymorphism in the promoter region of lncRNA GAS5 and the risk of hepatocellular carcinoma.Carcinogenesis2015https://conductscience.org/library/papers/26163879PubMed
1127774775Galactosylated Lipidoid Nanoparticles for Delivery of Small Interfering RNA to Inhibit Hepatitis C Viral Replication In Vivo.Adv Healthc Mater2016https://conductscience.org/library/papers/27774775PubMed
1232782576Long non-coding RNA GAS5 in human cancer.Oncol Lett2020https://conductscience.org/library/papers/32782576PubMed
1329792572GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics.Nucleic Acid Ther2018https://conductscience.org/library/papers/29792572PubMed
1438660664Construction of CDKN2A-related competitive endogenous RNA network and identification of GAS5 as a prognostic indicator for hepatocellular carcinoma.World J Gastrointest Oncol2024https://conductscience.org/library/papers/38660664PubMed
1515050913Focus on hepatocellular carcinoma.Cancer Cell2004https://conductscience.org/library/papers/15050913PubMed
1635116254Gain of GAS5 reveals worse prognosis in kidney renal clear cell carcinoma and liver hepatocellular carcinoma from the Cancer Genome Atlas dataset.Transl Cancer Res2021https://conductscience.org/library/papers/35116254PubMed
1733611339The role of m6A modification in the biological functions and diseases.Signal Transduct Target Ther2021https://conductscience.org/library/papers/33611339PubMed
1835736636Tumor Suppressive Effects of GAS5 in Cancer Cells.Noncoding RNA2022https://conductscience.org/library/papers/35736636PubMed
1932251383Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing.Nat Nanotechnol2020https://conductscience.org/library/papers/32251383PubMed
2033848519LncRNA-miRNA axes in breast cancer: Novel points of interaction for strategic attack.Cancer Lett2021https://conductscience.org/library/papers/33848519PubMed

See all 36 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
42886458LncRNA GAS5 Restrains Hepatocellular Carcinoma by Targeting the miR-18a-5p-CADM2 Axis.Biochem Genet2026https://conductscience.org/library/papers/42886458PubMed
42306183METTL3-Mediated m6A Modification of lncRNA-0949 Drives Microglial Inflammation in an vitro Model of Sepsis-Associated Encephalopathy.J Inflamm Res2026https://conductscience.org/library/papers/42306183PubMed
42288679STK39 promotes the evolution cascade of hepatocellular carcinoma by facilitating PKR/NF-κB-mediated macrophage inflammatory response.Oncogene2026https://conductscience.org/library/papers/42288679PubMed
42100423Plasma expression of long non-coding RNA GAS5 and its prognostic significance in newly diagnosed multiple myeloma.Front Oncol2026https://conductscience.org/library/papers/42100423PubMed
41474641Mechanistic Insights and Therapeutic Potential of Small Nucleolar RNA Host Genes in the Carcinogenesis of Hepatocellular Carcinoma.Cancer Med2026https://conductscience.org/library/papers/41474641PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40451925

GET https://conductscience.org/api/papers/v1/40451925/references?page=2